Massachusetts General Hospital: Stroke trials
The registry lists 12 Stroke studies with Massachusetts General Hospital as lead sponsor. 5 are open to participants now and 3 have results posted.
Phase 1 1Phase 2 3Phase 3 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke SurvivorsRecruitingNCT07414732Not applicable
- Promoting Recovery After Brain Injury Using Focused UltrasoundRecruitingNCT07277309Not applicable
- BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group EngagementRecruitingNCT07091851Not applicable
- Substrates for Post-Stroke Arm RehabilitationRecruitingNCT06998485Not applicable
- Stroke Motor Rehabilitation and Recovery StudyRecruitingNCT03485040
- Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in TanzaniaCompletedNCT03728153Phase 2Results posted
- Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial FibrillationCompletedNCT03702582Phase 3Results posted
- Normobaric Oxygen Therapy in Acute Ischemic Stroke TrialTerminatedNCT00414726Phase 2Results posted
- Immunomodulatory Effects of PCSK9 InhibitionWithdrawnNCT05720156
- Precision Medicine in Ischemic Stroke and Atrial FibrillationCompletedNCT04637087Not applicable
- Transcutaneous Vagus Nerve Stimulation for Motor Recovery After StrokeTerminatedNCT03292159Phase 1/2
- Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)CompletedNCT00000517Phase 3